ChemoRT With and Without Dental Stent for Taste Protection in NPC Patients
Condition(s) studied
Investigational drug(s) / intervention(s)
Dental stent: Dental stent is personalised device for tongue depressing and immobilisation during RT. The aims are to reduce unnecessary RT doses to adjacent non-target healthy tissue, including the tongue, adjacent oral mucosa, parotid glands/ submandibular glands, and temporomandibular joints. Dentists will take impression of the teeth on moulds, and measure the height to raise the bite, the stent is then fabricated as methyl methacrylate resin in the dental laboratory. The resin base extends to the tongue and a flat plate depresses the tongue. This device will be placed before each RT fraction.
No dental stent: No dental stent used during chemoradiation treatment
Study summary
Primary objective:
Evaluate and compare incidence of acute and long-term taste dysfunction in chemoradiation plus dental stent group vs. chemoradiation group, using objective-measured taste strip test, and patient-reported taste ability and toxicity.
Secondary objectives:
1. Evaluate and compare incidence of acute and long-term toxicities (excluding taste) and patient-reported quality of life between chemoradiation plus dental stent group and chemoradiation group.
2. Evaluate and compare tumor response, overall survival, and failure-free survival between chemoradiation plus dental stent group and chemoradiation group.
3. Analyze dosimetric parameters of taste bud bearing tongue mucosa, ipsilateral/ contralateral parotid and submandibular glands extracted from RT plans and correlate with taste impair
Eligibility
Primary outcome measure(s)
- Patient-assessed taste impairment using the QLQ-HN43 module — From baseline to 52 weeks post-RT
Patient-assessed taste impairment measured on 4-point verbal rating scale, ranging from none to severe using the QLQ-HN43 module. - Taste impairment assessed on NCI CTCAE version 5.0 grading — From baseline to 52 weeks post RT
Taste alterations (dysgeusia) will be graded between Grades 0 to 2. - Taste impairment measured on the STTA scale — From baseline to 52 weeks post-RT
The STTA scale modified from the Late Effects Normal Tissue/Subjective Objective Management Analytic is a scoring system for taste acuity ranging from Grades 0 to 4 - Objective testing using test strips — From baseline to 52 weeks post-RT
Taste strips are a validated approach to assess taste ability for the five primary taste modalities - sweet, sour, salty, bitter, and umami.
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Singapore Institute of Food and Biotechnology Innovation | Singapore | Singapore | Not Yet Recruiting |
| National University Hospital | Singapore | Singapore | Recruiting |
More National University Hospital, Singapore trials in Singapore
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06733948 on ClinicalTrials.gov ↗ ← All trials in Singapore